An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Apter, A., van Praag, H. M., Plutchik, R., Sevy, S., Korn, M. & Brown, S.-L. (1990). Interrelationship between anxiety, aggression, impulsivity and mood. A possible serotonergically-linked cluster. Psychiatry Research (in the press).Google Scholar
Arora, R. C. & Meltzer, H. Y. (1989). Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. American Journal of Psychiatry146, 730–776.Google ScholarPubMed
Asberg, M., Traskman, L. & Thoren, P. (1976). 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor?Archives of General Psychiatry33, 1193–1197.CrossRefGoogle ScholarPubMed
Asberg, M., Bertilsson, L., Matensson, B., Scalia-Tombia, G.-P., Thoren, P. & Traskman, L. (1984). CSF monoamine metabolites in melancholia. Acta Psychiatrica Scandinavica69, 201–210.CrossRefGoogle ScholarPubMed
Charney, D. S., Wood, S. W. & Henninger, J. R. (1987). Serotonin functions in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and health subjects. Psychopharmacology92, 14–24.CrossRefGoogle Scholar
Coccaro, E. F., Siever, L. J., Klar, H. M., Maurer, G., Cochrane, K., Cooper, T. B., Mohs, R. C. & Davis, K. L. (1989). Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry46, 587–599.CrossRefGoogle ScholarPubMed
Fishbein, D. H., Lozovsky, D. & Jaffe, J. H. (1989). Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation, in substance abusers. Biological Psychiatry25, 1049–1066.CrossRefGoogle ScholarPubMed
Invernizzi, R., Berettera, C., Garattini, S. & Samanin, R. (1986). D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. European Journal of Pharmacology120, 9–15.CrossRefGoogle ScholarPubMed
Kahn, R., Wetzler, S., van Praag, H. M. & Asnis, G. M. (1988a). Behavioral indications of serotonin receptor hypersensitivity in panic disorder. Psychiatry Research25, 101–104.CrossRefGoogle ScholarPubMed
Kahn, R., Wetzler, S., van Praag, H. M. & Asnis, G. M. (1988b). Neuroendocrine evidence for 5-HT receptor hypersensivity in patients with panic disorder. Psychopharmacology96, 360–364.CrossRefGoogle Scholar
Korn, M., Brown, S.-L. & van Praag, H. M. (1989). Serotonergic disturbances in suicide.Paper read at the World Congress of Psychiatry,Athens (in the press).Google Scholar
Korn, M. L., Kotler, M., Molcho, A., Grosz, D., Brown, S.-L., Chen, C. & van Praag, H. M. (1990). Suicide and aggression associated with panic attacks. Biological Psychiatry (submitted).Google Scholar
Linnoila, M., Virkhunen, M., Scheinin, M., Nuutila, A., Rimon, R. & Goodwin, F. K. (1983). Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sciences33, 2609–2614.CrossRefGoogle Scholar
Mann, J. J., Stanley, M., McBride, A. & McEwen, B. S. (1986). Increased serotonin2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry43, 954–959.CrossRefGoogle ScholarPubMed
Meltzer, H. Y., Perline, R., Tricoy, B. J., Lowy, M. T. & Robertson, A. (1984). Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relations to suicide, psychosis, and depressive symptoms. Archives of General Psychiatry41, 379–387.CrossRefGoogle ScholarPubMed
Morand, C., Young, J. N. & Ervin, F. R. (1983). Clinical response of aggressive schizophrenics to oral tryptophan. Biological Psychiatry18, 575–578.Google ScholarPubMed
Ninan, P. T., van Kammen, D. P., Scheinin, M., Linnoila, M., Bunney, W. E., & Goodwin, F. K. (1984). CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. American Journal of Psychiatry141, 566–569.Google ScholarPubMed
Olivier, B., van Dalen, D. & Hartog, J. (1986). A new class of psychotropic drugs: Serenics. Drugs of the Future11, 473–494.Google Scholar
Plutchik, R., van Praag, H. M. & Conte, H. R. (1989a). Correlates of suicide and violence risk. III. A two-stage model of countervailing forces. Psychiatry Research28, 215–225.CrossRefGoogle Scholar
Plulchik, R., van Praag, H. M., Picard, S., Conte, H. R. & Korn, M. (1989b). Is there a relaton between seriousness of suicide intent and the lethality of the suicide attempt?Psychiatry Research27, 71–79.CrossRefGoogle Scholar
Roy, A., & Linnoila, M. (1988). Suicidal behavior, impulsiveness and serotonin. Acta Psychiatrica Scandinavica78, 529–535.CrossRefGoogle ScholarPubMed
Roy, A., Adinoff, B. & Linnoila, M. (1988). Acting out hostility in normal volunteers: negative correlation with levels of 5-HIAA in cerebral spinal fluid. Psychiatry Research24, 187–194.CrossRefGoogle Scholar
Roy, A., Adinoff, B., Roehirch, L., Lamparski, D., Custer, R., Lorenz, V., Barbaccia, M., Guidotti, A., Costa, E. & Linnoila, M. (1988). Pathological gambling. Archives of General Psychiatry45, 369–373.CrossRefGoogle ScholarPubMed
Roy, A., Dejong, J. & Linnoila, M. (1989). Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. Archives of General Psychiatry46, 609–612.CrossRefGoogle ScholarPubMed
Soubrie, P. (1986). Reconciling the role of central serotonin neurons in human and nimal behavior. Behavioral and Nrain Sciences9, 319–363.CrossRefGoogle Scholar
Traskman, L., Asberg, M., Bertilsson, L. & Sjostrand, L. (1981). Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry38, 631–636.CrossRefGoogle ScholarPubMed
van Praag, H. M. (1982). Depression, suicide and the metabolism of serotonin in the brain. Journal of Affective Disorders4, 275–290.CrossRefGoogle Scholar
van Praag, H. M. (1983). CSF 5-HIAA and suicide in non-depressed schizophrenics. Lanceti, 977–978.CrossRefGoogle Scholar
van Praag, H. M. (1986a). (Auto)aggression and CSF 5-HIAA in depression and schizophrenia. Psychopharmacology Bulletin22, 669–673.Google ScholarPubMed
van Praag, H. M. (1986b). Biological suicide research: outcome and limitations. Biological Psychiatry21, 1305–1323.CrossRefGoogle ScholarPubMed
van Praag, H. M. (1988). Serotonergic mechanisms and suicidal behaviour. Psychiatry and Psychobiology3, 335–346.CrossRefGoogle Scholar
van Praag, H. M. & Korf, J. (1971). Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: a biochemical classification?Psychopharmacologia19, 148–152.CrossRefGoogle Scholar
van Praag, H. M. & Plutchik, R. (1985). An empirical study on the ‘cathartic effect’ of attempted suicide. Psychiatry Research16, 123–130.CrossRefGoogle Scholar
van Praag, H. M.Ulemann, A. M. & Spitz, J. C. (1965). The vital syndrome interview. A stuctured standard interview for the recognition and registration of the vital depression symptom complex. Psychiatrica Neurologia Neurochirurgia68, 329–346.Google Scholar
van Praag, H. M., Korf, J. & Puite, J. (1970). 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature225, 1259–1260.CrossRefGoogle ScholarPubMed
Virkkunen, M., Nuttila, A., Goodwin, F. K. & Linnoila, M. (1987). Cerebrospinal fluid monoamine metabolite levels in male arsonists. Archives of General Psychiatry44, 241–247.CrossRefGoogle ScholarPubMed
Virkkunen, M., DeJong, J., Bartko, J. & Linnoila, M. (1989). Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Archives of General Psychiatry46, 604–606.CrossRefGoogle ScholarPubMed
Volavka, J., Crowner, M., Brizer, D., Convit, A., van Praag, H. M. & Cooper, T. (1990). Tryptophan treatment of aggressive psychiatric patients. Biological Psychiatry (in the press).CrossRefGoogle Scholar
Weissman, M. M., Klerman, G. L.Markowitz, J. S. & Ouellette, R. (1989). Suicidal ideation and suicide attempt in panic disorder and attacks. New England Journal of Medicine321, 1209–1214.CrossRefGoogle ScholarPubMed